REGENXBIO Inc. (RGNX) Declined -6.4% or -3.42 To Price $50.01 On Wednesday


REGENXBIO Inc. (RGNX) declined -6.4% or -3.42 to $50.01. It is nearly 894075 shares traded, which is 198.14% compare to the average total volume 451237. The market cap of RGNX is $1.79 billion. The year to date change is 47.35%. The 52 week price range is from $23.25 to $85.1. Price of RGNX have changed -11.80% during last week. It have changed -15.13% over last month, -28.36% over last 3 months, -6.78% over last 6 months and 80.44% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RGNX is 63.27. It is 26.51% above current price. The 200-day Moving Averages for RGNX is 56.63. It is 13.24% above current price. The 52-week High is 85.1. It is 70.17% from the current price. The 52-week Low is 23.25. It is -53.51% from current price.

There are some statistics of RGNX. It is has market cap $1.79 billion. The share outstanding is 35.84 million. The average volume is 451237. The percent of top 15 Institution holding is 121.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RGNX is 23.19%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RGNX is 22.06%.


Tags:

Share this post